Afrocentric: health care ‘needs to be less costly’

The holding company says the SA operating environment has been ‘burdened’ with economic and political challenges

AfroCentric’s share price unchanged despite doubling HEPS

AfroCentric ups its dividend to 16c for the year to end-June

Aspen sinks on sale of baby milk business

Unit sold to French dairy giant Lascalis for $860m, short of the $1bn-$1.5bn the market expected

BL PREMIUM
Aspen sheds R18.5bn on sale of baby milk business

The unit was sold to French dairy giant Lascalis for $860m, short of the $1bn-$1.5bn the market expected

Aspen sells baby formula unit to French dairy group Lactalis

The drugmaker's shares have fallen sharply after it released full-year results and announced the sale

Medicines, not sicker patients, push up costs, says latest Mediscor review

The medical benefit management company’s latest review shows medicine expenditure per beneficiary up 6.9% in 2017

Aspen slides as rand hits revenue

Emerging markets were expected to continue to be the most important contributor to growth for Africa’s largest drug manufacturer

Mediclinic pays R1bn for controlling stake in Swiss consolidation

The merger will combine its Geneva-based Clinique La Colline with the privately held Clinique de Grangettes

Big three will be the death of the day hospital sector, industry body warns

The Day Hospital Association wants competition authorities to prohibit Mediclinic’s acquisition of Intercare

Slow growth halts Advanced Health's plans

Advanced Health puts expansion on ice and will revisit empowerment when it posts no loss

Advanced Health uses healthier Australian unit to stem bleeding from local operation

The day clinic operator says equipment purchases are less than they have been, which should bode well for its future cash flow position

Adcock eyes deals in new segments

Company plans to reduce exposure to the single exit price mechanism

Pharmaceutical makers push for extra price rise

Falling value of rand squeezes manufacturers’ profit margins on imported ingredients

Selfmed to pay director more than R1m over disputed leave policy

Martha Bester was owed 218 days of accrued leave in 2014, but paid for only 45 of them; the judge says she was more credible than a company representative

Necsa inks deal for tech used in nuclear medicine with Russia’s Rusatom Healthcare

In terms of the deal, two small ‘solution reactors’ will be built in SA as well as a commercial cyclotron for the production of radio-pharmaceuticals

Pharma Dynamics to recall drugs possibly tainted with cancer-causing toxins

Sahpra says the drugs affected are commonly used to treat people with high blood pressure, to reduce complications such as heart attack and stroke

Subscribe to BL premium

Published by Tiso Blackstar and distributed with the Financial Mail on the last Thursday of every month except December and January.